Bracebridge Capital LLC’s HH&L Acquisition Co. Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 HHLA.WS Stock Holding History

Bracebridge Capital LLC’s Portfolio HHLA.WS Stock Details HHLA.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-42,531	Closed	-$1.06K	–	51
2023 Q4	$1.06K	Hold	42,531	–	–	﹤0.01%	41
2023 Q3	$1.2K	Hold	42,531	–	–	﹤0.01%	47
2023 Q2	$851	Hold	42,531	–	–	﹤0.01%	61
2023 Q1	$2.67K	Buy	+42,531	New	+$3.51K	﹤0.01%	64

Bracebridge Capital LLC's HHLA.WS Position: Q1 2024 in Review

Bracebridge Capital LLC sold out of HH&L Acquisition Co. Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (HHLA.WS) in Q1 2024, closing a stake of 42,531 shares — an estimated $1.06K sold.

Bracebridge Capital LLC first reported a position in HHLA.WS in Q1 2023 and held it in 4 quarters. The position peaked at $2.67K in Q1 2023. 0 funds tracked by Wall St. Rank hold HHLA.WS as of Q1 2024.

Bracebridge Capital LLC reported no remaining HH&L Acquisition Co. Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q1 2024 after selling out during the quarter.
Bracebridge Capital LLC sold 42,531 HH&L Acquisition Co. Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q1 2024, an estimated $1.06K.
Bracebridge Capital LLC first reported a position in HH&L Acquisition Co. Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q1 2023 and held it in 4 quarters.
Bracebridge Capital LLC's HH&L Acquisition Co. Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $2.67K in Q1 2023.
0 funds tracked by Wall St. Rank held HH&L Acquisition Co. Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q1 2024.

Based on Bracebridge Capital LLC's 13F filing for Q1 2024, filed 10 May 2024.